Tuberculosis in prisons: an integrated prevention and care cascade for a persistent structural epidemic
Jaen Cagua-Ordoñez1, Juan Marcos Parise-Vasco1, Jaime Angamarca-Iguago1
1Center for Evidence, Implementation, and Health Decision-Making (CIDES), Facultad de Ciencias de la Salud y Bienestar Humano, Universidad Tecnológica Indoamérica, Ambato, Ecuador.
Frontiers in Public Health
|July 23, 2026
Summary
Tuberculosis (TB) is a major issue in prisons globally. Improving screening, diagnosis, treatment, and post-release care, alongside better ventilation and integrated TB/HIV services, is crucial for effective prison TB control.
Area of Science:
- Public Health
- Infectious Disease Epidemiology
- Correctional Healthcare
Background:
- Tuberculosis (TB) disproportionately affects prison populations worldwide due to factors like overcrowding and HIV co-infection.
- Weak integration between correctional health and national TB programs exacerbates the problem.
Purpose of the Study:
- To synthesize evidence on the prison TB prevention and care cascade.
- To identify gaps and effective strategies for TB control in correctional settings.
Main Methods:
- Structured narrative review using systematic review principles.
- Expert-led synthesis of direct prison-specific evidence and related fields.
Main Results:
- Symptom screening alone is insufficient; digital chest radiography with molecular testing improves detection.
- Rapid molecular tests (Xpert MTB/RIF or Ultra) are key for diagnosis and resistance detection.
- Shorter TB infection and MDR/RR-TB regimens show promise, but require more study in prisons.
- Ventilation, integrated TB/HIV services, and peer support aid transmission reduction.
- Post-release continuity of care is a significant implementation gap.
Conclusions:
- Sustainable prison TB control needs an integrated, measurable prison-community cascade.
- This includes improved screening, rapid diagnosis, effective treatment, environmental controls, and post-release linkage to care.
Related Concept Videos
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Healthcare Associated Infections II: Preventive Measures
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

